Nov 20 (Reuters) - Orion Oyj ORNBV.HE :
* RECEIVES FDA APPROVAL FOR BONQAT® (PREGABALIN ORAL
SOLUTION)
* APPROVAL OF BONQAT FOR ALLEVIATION OF ACUTE ANXIETY AND
FEAR
ASSOCIATED WITH TRANSPORTATION AND VETERINARY VISITS IN CATS
* ORION'S LONG-STANDING STRATEGIC PARTNER, ZOETIS, HAS
EXCLUSIVE
RIGHT TO MARKET AND SELL BONQAT IN UNITED STATES
* BONQAT IS ANTICIPATED TO BE AVAILABLE IN U.S. BY MID-2024
Source text for Eikon: ID:nGNEBD93d
Further company coverage: ORNBV.HE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))